CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues	$ 591,187	$ 552,968	$ 1,162,601	$ 1,109,357
Cost of service, inclusive of depreciation	326,933	297,455	648,470	612,465
General and administrative expenses:
Salaries and benefits	129,323	125,504	257,269	251,843
Non-cash compensation	7,828	9,083	15,261	12,356
Merger-related expenses	11,901	19,451	32,568	20,171
Depreciation and amortization	4,386	4,725	8,657	9,168
Other	58,602	58,955	116,543	123,180
Total operating expenses	538,973	515,173	1,078,768	1,029,183
Operating income	52,214	37,795	83,833	80,174
Other income (expense):
Interest income	1,617	742	3,344	1,148
Interest expense	(7,895)	(7,502)	(16,014)	(15,019)
Equity in earnings from equity method investments	1,515	7,991	2,425	8,114
Merger termination fee	0	(106,000)	0	(106,000)
Miscellaneous, net	1,779	4,743	2,869	4,061
Total other expense, net	(2,984)	(100,026)	(7,376)	(107,696)
Income (loss) before income taxes	49,230	(62,231)	76,457	(27,522)
Income tax expense	(16,657)	(18,250)	(29,290)	(28,050)
Net income (loss)	32,573	(80,481)	47,167	(55,572)
Net (income) loss attributable to noncontrolling interests	(272)	206	(466)	543
Net income (loss) attributable to Amedisys, Inc.	$ 32,301	$ (80,275)	$ 46,701	$ (55,029)
Basic earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders	$ 0.99	$ (2.46)	$ 1.43	$ (1.69)
Weighted average shares outstanding, basic (shares)	32,706	32,579	32,688	32,568
Diluted earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders	$ 0.98	$ (2.46)	$ 1.42	$ (1.69)
Weighted average shares outstanding, diluted (shares)	33,047	32,579	32,992	32,568